These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29785825)

  • 1. Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.
    Kraemer KH; Tamura D; Khan SG
    Br J Dermatol; 2018 May; 178(5):1009. PubMed ID: 29785825
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum.
    Salomon G; Maza A; Boulinguez S; Paul C; Lamant L; Tournier E; Mazereeuw-Hautier J; Meyer N
    Br J Dermatol; 2018 May; 178(5):1199-1203. PubMed ID: 29274233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab.
    Hauschild A; Eichstaedt J; Möbus L; Kähler K; Weichenthal M; Schwarz T; Weidinger S
    Eur J Cancer; 2017 May; 77():84-87. PubMed ID: 28365530
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.
    Deinlein T; Lax SF; Schwarz T; Giuffrida R; Schmid-Zalaudek K; Zalaudek I
    Eur J Cancer; 2017 Sep; 83():99-102. PubMed ID: 28734147
    [No Abstract]   [Full Text] [Related]  

  • 5. Xeroderma pigmentosum showing common skin cancers plus melanocarcinoma controlled by surgery.
    MOORE C; IVERSON PC
    Cancer; 1954 Mar; 7(2):377-82. PubMed ID: 13141232
    [No Abstract]   [Full Text] [Related]  

  • 6. Facial resurfacing with a monoblock full-thickness skin graft after multiple malignant melanomas excision in xeroderma pigmentosum.
    Ozmen S; Uygur S; Eryilmaz T; Ak B
    J Craniofac Surg; 2012 Sep; 23(5):1542-3. PubMed ID: 22976654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic response to nivolumab in xeroderma pigmentosum skin tumor.
    Chambon F; Osdoit S; Bagny K; Moro A; Nguyen J; Réguerre Y
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MULTIPLE MALIGNANT TUMOUR FORMATION IN XERODERMA PIGMENTOSUM.
    YOSIPOVITCH Z; SACHS MI; NEUMAN Z
    Br J Plast Surg; 1965 Jul; 18():314-22. PubMed ID: 14327059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple melanoma in xeroderma pigmentosum].
    Fölster-Holst R; Schubert C; Christophers E
    Hautarzt; 1994 Aug; 45(8):554-61. PubMed ID: 7960757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melanoma in xeroderma pigmentosum: 12 cases].
    Fazaa B; Zghal M; Bailly C; Zeglaoui F; Goucha S; Mokhtar I; Kharfi M; Ezzine N; Kamoun MR
    Ann Dermatol Venereol; 2001 Apr; 128(4):503-6. PubMed ID: 11395647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [XERODERMA PIGMENTOSUM WITH BASAL CELL AND SPINOCELLULAR EPITHELIOMA AND MELANOMA].
    GAUMOND E
    Hautarzt; 1964 Aug; 15():448-50. PubMed ID: 14249295
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer in families with xeroderma pigmentosum.
    Swift M; Chase C
    J Natl Cancer Inst; 1979 Jun; 62(6):1415-21. PubMed ID: 286113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of xeroderma pigmentosum.
    Copeland NE; Hanke CW; Michalak JA
    Dermatol Surg; 1997 Jun; 23(6):447-55. PubMed ID: 9217796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple melanomas occurring in a patient with xeroderma pigmentosum.
    Tullis GD; Lynde CW; McLean DI; Stewart WD
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):364-7. PubMed ID: 6480943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear morphometry in xeroderma pigmentosum-associated malignant melanomas.
    Fazaa B; Piérard-Franchimont C; Zghal M; Kamoun MR; Piérard GE
    Am J Dermatopathol; 1994 Dec; 16(6):611-4. PubMed ID: 7864298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [XERODERMA PIGMENTOSUM. 8 CASES OF DIFFERENT EVOLUTION IN 2 FAMILIES].
    LEMAIRE M; GAUMOND E
    Can Med Assoc J; 1965 Feb; 92(8):406-12. PubMed ID: 14261153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xeroderma pigmentosum in Qatar.
    Fathy S; Khafagy H
    Cutis; 1986 May; 37(5):377-9. PubMed ID: 3709228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic problems of desmoplastic melanoma in a boy with xeroderma pigmentosum.
    Schulz H; Noebel A
    Dermatol Surg; 1996 Jan; 22(1):95-6. PubMed ID: 8556265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.